121 related articles for article (PubMed ID: 35466412)
1. Xanthatin inhibits non-small cell lung cancer proliferation by breaking the redox balance.
Xie Y; Zhu X; Liu P; Liu Y; Geng Y; Zhang L
Drug Dev Res; 2022 Aug; 83(5):1176-1189. PubMed ID: 35466412
[TBL] [Abstract][Full Text] [Related]
2. Xanthatin suppresses pancreatic cancer cell growth via the ROS/RBL1 signaling pathway: In vitro and in vivo insights.
Geng Y; Liu P; Xie Y; Liu Y; Zhang X; Hou X; Zhang L
Phytomedicine; 2023 Oct; 119():155004. PubMed ID: 37562091
[TBL] [Abstract][Full Text] [Related]
3. A new xanthatin analogue 1β-hydroxyl-5α-chloro-8-epi-xanthatin induces apoptosis through ROS-mediated ERK/p38 MAPK activation and JAK2/STAT3 inhibition in human hepatocellular carcinoma.
Fang XY; Zhang H; Zhao L; Tan S; Ren QC; Wang L; Shen XF
Biochimie; 2018 Sep; 152():43-52. PubMed ID: 29960031
[TBL] [Abstract][Full Text] [Related]
4. Concerted suppression of STAT3 and GSK3β is involved in growth inhibition of non-small cell lung cancer by Xanthatin.
Tao L; Fan F; Liu Y; Li W; Zhang L; Ruan J; Shen C; Sheng X; Zhu Z; Wang A; Chen W; Huang S; Lu Y
PLoS One; 2013; 8(11):e81945. PubMed ID: 24312384
[TBL] [Abstract][Full Text] [Related]
5. Xanthatin induce DDP-resistance lung cancer cells apoptosis through regulation of GLUT1 mediated ROS accumulation.
Liu Y; Zhang X; Cheng F; Cao W; Geng Y; Chen Z; Wei W; Zhang L
Drug Dev Res; 2023 Sep; 84(6):1266-1278. PubMed ID: 37260173
[TBL] [Abstract][Full Text] [Related]
6. Xanthatin mediates G
Geng YD; Zhang L; Wang GY; Feng XJ; Chen ZL; Jiang L; Shen AZ
Nat Prod Res; 2020 Sep; 34(18):2616-2620. PubMed ID: 30587055
[TBL] [Abstract][Full Text] [Related]
7. Xanthatin anti-tumor cytotoxicity is mediated via glycogen synthase kinase-3β and β-catenin.
Tao L; Sheng X; Zhang L; Li W; Wei Z; Zhu P; Zhang F; Wang A; Woodgett JR; Lu Y
Biochem Pharmacol; 2016 Sep; 115():18-27. PubMed ID: 27321043
[TBL] [Abstract][Full Text] [Related]
8. (-)-Xanthatin induces the prolonged expression of c-Fos through an N-acetyl-L-cysteine (NAC)-sensitive mechanism in human breast cancer MDA-MB-231 cells.
Takeda S; Nishimura H; Koyachi K; Matsumoto K; Yoshida K; Okamoto Y; Amamoto T; Shindo M; Aramaki H
J Toxicol Sci; 2013; 38(4):547-57. PubMed ID: 23824011
[TBL] [Abstract][Full Text] [Related]
9. Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells.
Zhang L; Ruan J; Yan L; Li W; Wu Y; Tao L; Zhang F; Zheng S; Wang A; Lu Y
Molecules; 2012 Mar; 17(4):3736-50. PubMed ID: 22450683
[TBL] [Abstract][Full Text] [Related]
10. Xanthatin inhibits human colon cancer cells progression via mTOR signaling mediated energy metabolism alteration.
Li L; Liu P; Xie Y; Liu Y; Chen Z; Geng Y; Zhang L
Drug Dev Res; 2022 Feb; 83(1):119-130. PubMed ID: 34180556
[TBL] [Abstract][Full Text] [Related]
11. CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment.
Kawano Y; Iwama E; Tsuchihashi K; Shibahara D; Harada T; Tanaka K; Nagano O; Saya H; Nakanishi Y; Okamoto I
Lung Cancer; 2017 Nov; 113():72-78. PubMed ID: 29110853
[TBL] [Abstract][Full Text] [Related]
12. Xanthatin synergizes with cisplatin to suppress homologous recombination through JAK2/STAT4/BARD1 axis in human NSCLC cells.
Zhang J; Yang S; Guan H; Zhou J; Gao Y
J Cell Mol Med; 2021 Feb; 25(3):1688-1699. PubMed ID: 33439503
[TBL] [Abstract][Full Text] [Related]
13. Xanthatin induces glioma cell apoptosis and inhibits tumor growth via activating endoplasmic reticulum stress-dependent CHOP pathway.
Ma YY; Di ZM; Cao Q; Xu WS; Bi SX; Yu JS; Shen YJ; Yu YQ; Shen YX; Feng LJ
Acta Pharmacol Sin; 2020 Mar; 41(3):404-414. PubMed ID: 31700088
[TBL] [Abstract][Full Text] [Related]
14. (-)-Xanthatin up-regulation of the GADD45γ tumor suppressor gene in MDA-MB-231 breast cancer cells: role of topoisomerase IIα inhibition and reactive oxygen species.
Takeda S; Noguchi M; Matsuo K; Yamaguchi Y; Kudo T; Nishimura H; Okamoto Y; Amamoto T; Shindo M; Omiecinski CJ; Aramaki H
Toxicology; 2013 Mar; 305():1-9. PubMed ID: 23313378
[TBL] [Abstract][Full Text] [Related]
15. Xanthatin triggers Chk1-mediated DNA damage response and destabilizes Cdc25C via lysosomal degradation in lung cancer cells.
Tao L; Cao Y; Wei Z; Jia Q; Yu S; Zhong J; Wang A; Woodgett JR; Lu Y
Toxicol Appl Pharmacol; 2017 Dec; 337():85-94. PubMed ID: 29074359
[TBL] [Abstract][Full Text] [Related]
16. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Park WH
Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
[TBL] [Abstract][Full Text] [Related]
17. Combination of 2-deoxy d-glucose and metformin for synergistic inhibition of non-small cell lung cancer: A reactive oxygen species and P-p38 mediated mechanism.
Hou XB; Li TH; Ren ZP; Liu Y
Biomed Pharmacother; 2016 Dec; 84():1575-1584. PubMed ID: 27825799
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin B potently suppresses non-small-cell lung cancer growth: identification of intracellular thiols as critical targets.
Kausar H; Munagala R; Bansal SS; Aqil F; Vadhanam MV; Gupta RC
Cancer Lett; 2013 May; 332(1):35-45. PubMed ID: 23340170
[TBL] [Abstract][Full Text] [Related]
19. 8-Epi-xanthatin induces the apoptosis of DU145 prostate carcinoma cells through signal transducer and activator of transcription 3 inhibition and reactive oxygen species generation.
Lee YJ; Choi J; Yoon YJ; Sim Y; Ryu HW; Oh SR; Kim DY; Hwang J; Chi SW; Han DC; Kwon BM
Phytother Res; 2021 Mar; 35(3):1508-1520. PubMed ID: 33164240
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
Zheng CY; Lam SK; Li YY; Ho JC
Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
